| Financial Year |
March 31 2023 |
| Monetary Funds |
5,389,659,958.68 |
| Held-for-trading Financial Assets |
4,421,256.02 |
| Notes Receivable |
59,720,633.48 |
| Accounts Receivable |
4,068,297,228.52 |
| Advances to Suppliers |
338,309,875.52 |
| Other Receivables |
248,025,210.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,027,102,684.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,095,137.40 |
| Other Current Assets |
978,326,405.29 |
| Total Current Assets |
14,619,623,845.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
89,592,268.35 |
| Long-term Equity Investment |
3,103,153,447.34 |
| Investment Properties |
465,221,223.70 |
| Fixed Assetes |
26,082,633,850.21 |
| Under-construction Projects |
5,830,200,889.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,523,048,115.92 |
| R&D expenses |
-- |
| Goodwill |
584,483,918.21 |
| Long-Term Deferred and Prepaid Expenses |
36,284,064.99 |
| Deferred Income Tax Assets |
359,278,837.71 |
| Other Non-Current Assets |
305,146,890.18 |
| Sub-Total of Non-Current Assets |
39,830,467,170.75 |
| Total Assets |
54,450,091,016.58 |
| Short-Term Loans |
16,675,307,971.39 |
| Trading Financial liabilities |
1,820,000.00 |
| Notes Payable |
575,914,914.44 |
| Accounts Payable |
3,779,457,967.50 |
| Accounts Received In Advance |
77,720.19 |
| Employee Compensation Payable |
184,157,178.19 |
| Taxes Payable |
387,064,283.57 |
| Interest Payable |
-- |
| Dividend Payable |
8,455.72 |
| Other payables |
257,814,352.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,187,641,024.72 |
| Other Current Liabilities |
16,233,071.02 |
| Sub-Total of Current Liabilities |
25,190,358,260.18 |
| Long-term Loans |
7,249,323,244.82 |
| Bonds Payable |
4,317,019,084.01 |
| Long-Term Accounts Payable |
1,358,647,223.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,062,749.19 |
| Deferred Income Tax Liabilities |
329,448,446.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,017,793,842.10 |
| Total Liabilities |
39,208,152,102.28 |
| Paid-In Capital(Or Share Stock) |
3,305,958,951.00 |
| Capital Surplus |
4,538,416,940.47 |
| Surplus Reserve |
446,120,188.60 |
| LESS:Treasury Stock |
939,966,452.48 |
| Undistributed Profits |
5,808,266,942.06 |
| Minority Stockholder's Interest |
2,038,732,950.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,203,205,963.99 |
| Owner's Equity（Stockholder's Equity） |
15,241,938,914.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
54,450,091,016.58 |
